Mark Mirochnick, M.D. is Professor of Pediatrics and a member of the Division of Neonatology at Boston University School of Medicine/Boston Medical Center. He has extensive experience in clinical trials investigating the clinical pharmacology of antiretrovirals and TB drugs in neonates, infants, children and pregnant women. He has served as protocol chair, vice-chair, investigator and/or protocol pharmacologist on more than 25 perinatal and pediatric HIV protocols in the US, Africa, South America and Asia sponsored by NIAID, NICHD and CDC. He currently serves as co-chair of the US Perinatal HIV Guidelines Committee and is a member of the US Pediatric HIV Guidelines Committee and the WHO Pediatric Antiretroviral Working Group.
Conflict of Interest: Dr. Mirochnick has reported having potential financial conflicts of interest within the past 12 months, or anticipated within the coming 12 months, with the following entities: Merck, ViiV, Gilead, ReViral.